Protein–polymer therapeutics: a macromolecular perspective
The development of protein–polymer hybrids emerged several decades ago with the vision
that their synergistic combination will offer macromolecular hybrids with manifold features to …
that their synergistic combination will offer macromolecular hybrids with manifold features to …
Intravenous cyclophosphamide therapy of severe SLE
WJ McCune, D Fox - Rheumatic disease clinics of North America, 1989 - Elsevier
Intravenous cyclophosphamide therapy of severe systemic lupus is associated with
reduction in the numbers of circulating T and B lymphocytes, suppression of T11 (CD2) …
reduction in the numbers of circulating T and B lymphocytes, suppression of T11 (CD2) …
Cyclophosphamide augments ADCC by increasing the expression of Fc-receptors
MS Palermo, M Giordano, GP Serebrinsky, JR Geffner… - Immunology letters, 1987 - Elsevier
Previous reports demonstrated that cyclophosphamide (Cy) enhances two Fcγ receptor
(FcγR) mediated functions: antibody-dependent cellular cytotoxicity (ADCC) and …
(FcγR) mediated functions: antibody-dependent cellular cytotoxicity (ADCC) and …
Immunosuppressive agents: biologic effects in vivo and in vitro
WJ McCune, DA Fox - Lupus: Molecular and Cellular Pathogenesis, 1999 - Springer
This chapter reviews information on the biologic effects of immunosuppressive agents used
in the treatment of systemic lupus erythematosus (SLE), with a focus on effects on the …
in the treatment of systemic lupus erythematosus (SLE), with a focus on effects on the …
HER-2/neu protein-receptor-positive breast carcinoma: an immunologic perspective
RE Brown, AM Bernath… - Annals of Clinical & …, 2000 - Assoc Clin Scientists
Immunotherapy using a monoclonal antibody against the human epidermal growth factor
receptor 2 protein, HER-2/neu, has proven to be clinically efficacious in about one-half of …
receptor 2 protein, HER-2/neu, has proven to be clinically efficacious in about one-half of …
[HTML][HTML] Evaluating antitumor activity of Kiatomab by targeting cancer stem cell-specific KIAA1114 antigen in mice
SW Kim, HW Park, H Kim, S Lee, SY Choi… - Immune …, 2019 - synapse.koreamed.org
A full-length translational product of the trophinin gene, KIAA1114, is a distinctive marker of
cancer stem cells in human hepatocellular carcinoma, and a mAb, Kiatomab, is specific to …
cancer stem cells in human hepatocellular carcinoma, and a mAb, Kiatomab, is specific to …
Niektore aspekty supresyjnego oddzialywania chemioterapeutykow na reakcje immunologiczne ustroju
Z Gradzki - Medycyna Weterynaryjna, 1993 - agro.icm.edu.pl
Niektore aspekty supresyjnego oddzialywania chemioterapeutykow na reakcje
immunologiczne ustroju - Medycyna Weterynaryjna - Tom 49, Numer 05 (1993) - AGRO …
immunologiczne ustroju - Medycyna Weterynaryjna - Tom 49, Numer 05 (1993) - AGRO …
[PDF][PDF] Immunosuppressive Agents
BEI Vivo - Contemporary Immunology - ndl.ethernet.edu.et
This chapter reviews information on the biologic effects of immunosuppressive agents used
in the treatment of systemic lupus erythematosus (SLE), with a focus on effects on the …
in the treatment of systemic lupus erythematosus (SLE), with a focus on effects on the …
[引用][C] Ciclosporin therapy of autoimmune diseases
JM Cruse, RE Lewis Jr - Concepts in immunopathology, 1989 - pascal-francis.inist.fr
Ciclosporin therapy of autoimmune diseases CNRS Inist Pascal-Francis CNRS Pascal and
Francis Bibliographic Databases Simple search Advanced search Search by classification …
Francis Bibliographic Databases Simple search Advanced search Search by classification …